April 24, 2009 (FinancialWire) — Centerra Gold Inc. (OTC: CAGDF) (TSX: CG) said it has reached an agreement with the government of the Kyrgyz Republic and Cameco Corp. that resolves all of the existing disputes between Centerra and the government.

According to Centerra, the agreement provides for the Kyrgyz government’s full support for Centerra’s continuing long-term development of the Kumtor project. On June 2, 2008, the company reported that a previously agreed framework agreements entered into between the company, Cameco and the government in August of 2007 had not been ratified by the Kyrgyz parliament within the time frame agreed by the parties and had therefore expired.

Subsequently, the parties resumed their discussions and negotiations. Centerra said that the current agreement reflects the outcome of those negotiations.

Centerra claims Kumtor produces around 600,000 ounces of gold annually. It has operated uninterrupted since 1997. The gold mine has 2,300 employees.

The new agreement expands the company’s existing concession area and provides that Centerra will pay to the Government around $22.4 million, among other provisions.

Canada-based Centerra is a gold company focused on acquiring, exploring, developing and operating gold properties primarily in Asia, the former Soviet Union and other emerging markets worldwide.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.